Avio Smart Market to buy minority stake in Huwel Lifesciences

Avio Smart Market to buy minority stake in Huwel Lifesciences

Avio Smart Market Stack Acquires Minority Stake in Huwel Lifesciences

Avio Smart Market Stack Limited (formerly Bartronics India Limited) has approved a ₹15 crore investment in Huwel Lifesciences Private Limited, marking its strategic foray into the life sciences sector. The investment, announced on February 27, 2026, will be deployed in two equal tranches of ₹7.50 crore each, acquiring a 4.25% equity stake at ₹7,760 per share. The agreement also includes a strategic business collaboration with revenue-sharing terms, granting Avio Smart Market Stack 40% of net project revenue from initiatives facilitated by Huwel.

Huwel Lifesciences, a Hyderabad-based molecular diagnostics firm, specializes in infectious disease solutions. Its product portfolio includes the Quantiplus TB Fast Detection Kit, approved by India's ICMR, and Uniamp point-of-care devices, which have secured orders from the World Health Organization. The company's focus on emerging markets aligns with Avio's strategy to expand its footprint in global health programs.

Avio Smart Market Stack, rebranded from Bartronics India Limited on February 23, 2026, emphasized regulatory compliance in its transaction structure. The investment was approved following SEBI guidelines, with no related-party transaction disclosures. A Share Subscription cum Shareholders' Agreement (SSSHA) will govern the partnership, outlining operational and financial obligations.

The collaboration aims to leverage Huwel's diagnostic innovations and Avio's distribution capabilities, targeting growth in markets such as Africa and Southeast Asia. While the equity stake is relatively small, the revenue-sharing model introduces recurring income potential, diversifying Avio's revenue streams beyond its core technology services.

This move underscores Avio's broader strategy to integrate healthcare technology with financial services, reflecting growing investor interest in cross-sector partnerships. With Huwel's WHO ties and Avio's rebranding momentum, the alliance positions both firms to capitalize on India's expanding life sciences and diagnostics markets.

[^NUMBER]: Citations correspond to source materials provided.